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http://dx.doi.org/10.1016/j.kjms.201Abstract The aim of the present study is to review the recurrence patterns and incidence of sec-
ond primary tumors (SPTs) in patients with oral squamous cell carcinoma (OSCC) who underwent
surgery alone without postoperative adjuvant therapy. Data on patients recorded in the head
and neck cancer registry of Cathay General Hospital were reviewed. A total of 72 patients with
T1-3N0 OSCC who underwent surgery alone were included. Among the 72 patients, 44 had T1 tu-
mors, 22 had T2 tumors, and 6 had T3 tumors. The 5-year overall survival (OS) rate was 77.3%,
the recurrence-free survival rate was 74.1%, and the SPT-free survival rate was 73%. Eighteen
(25%) patients had disease recurrence (regional recurrence in nine patients, local recurrence in
seven patients, and locoregional recurrence in two patients). Most patients with local recurrence
alone (6/7 patients, 85.7%) could be salvaged with treatment. However, locoregional control was
obtained in only five (45.5%) of 11 patients with neck recurrence after surgical salvage therapy. At
the time of analysis, 20 patients developed SPTs, and 15 (75%) of the SPTs were in the oral cavity.
The annual incidence of SPT was 5%. Neck recurrence and SPT were associated with 48.4% and
24.4% lower 5-year OS rates, respectively. Multivariate analysis revealed that neck recurrence
was a significant risk factor for low OS (pZ 0.008). Neck recurrence was themost important prog-
nostic factor forOS.The incidenceof SPTdevelopmentwashigh.Regularand long-termmonitoring
for recurrence and development of SPTs is necessary to improve the survival rate.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.of Otolaryngology, Head and Neck Surgery, Cathay General Hospital, 280 Jen-Ai Road, Section 4, Taipei,
w (Y.-L. Chang).
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Surgery alone for localized oral cancer 555Introduction All statistical analyses were performed with the statis-Table 1 KaplaneMeier survival analysis of 5-year overall
survival (OS) rate.
Variables 5-y OS
% p
Age
40 (16) 67 0.157
<40 (56) 80.2
Gender
Male (60) 74.8 0.168
Female (12) 88.9
Betel nut chewing
Yes (43) 74.3 0.349
No (29) 81.1
Primary site
Tongue (31) 65.1 0.126
Buccal area (28) 87.1
Others (13) 84.6
Tumor classification
T1 (44) 82.1 0.317
T2 and T3 (28) 69.4
Tumor differentiation
Well (38) 77.3 0.860
Moderate/poor (34) 76.7
Neck dissection
Yes (32) 81.8 0.758
No (40) 74
Positive surgical margins, PNI, or LVP
Yes (11) 43.8 0.132
No (61) 81.2
Neck recurrence
Yes (11) 35.8 <0.001
No (61) 84.2
Local recurrence
Yes (9) 63.5 0.347
No (63) 79.4
SPT
Yes (20) 60.5 0.046
No (52) 84.9
LVP Z lymphovascular permeation; PNI Z perineural invasion;
SPT Z second primary tumor.The incidence of oral squamous cell carcinoma (OSCC) is
increasing rapidly in Asia and the South Pacific,which includes
Taiwan. In addition to smoking and drinking alcohol, betel
quid chewing has been identified as a significant etiological
factor in this area [1]. Conventional treatment of OSCC in-
cludes a combination of surgery, radiotherapy, and chemo-
therapy. Locoregionally recurrent disease contributes to the
majority of cancer-related deaths in patients with OSCC.
Another significant problem is the high incidence rate of
second primary tumors (SPTs), which has the greatest impact
on survival rates in patients with limited initial tumors [2].
Although studies have investigated the survival rate and
patterns of recurrence in patients who underwent surgery
alone for early stage OSCC [3e6], few studies have
analyzed the occurrence of SPTs in OSCC patients treated
with surgery alone. In this study, we evaluated the survival
rates, recurrence patterns, prognostic factors, and effects
of salvage treatment in 72 patients with localized (T1-3N0)
oral cancer. The incidence and pattern of SPT development
were also analyzed in order to evaluate the impact of
recurrent disease and SPTs on survival of OSCC patients
treated with surgery alone.
Materials and methods
Data on patients, recorded in the head and neck cancer
registry of Cathay General Hospital, who underwent surgi-
cal treatment for OSCC from January 1998 to May 2008 were
reviewed. One hundred and thirty patients with previously
untreated OSCC were treated primarily with surgery. A
total of 72 patients (55.4%) were included in our study. This
retrospective study was approved by the hospital’s insti-
tutional review board.
Inclusion criteria included localized (T1-3) squamous cell
carcinoma (SCC) of the oral cavity, no palpable cervical
nodes on physical examination or radiographic evidence of
node enlargement, postoperative pathological examination
showing absence of nodal metastases in patients who un-
derwent neck dissection, and treatment with surgery alone
without any adjuvant treatment modalities.
Indications for surgery alone for the treatment of SCC of
the oral cavity in our institution were as follows: T1, T2, or
T3 stage primary tumors, no pathologic evidence of nodal
disease (N0), free surgical margins, and absence of peri-
neural invasion (PNI) and lymphovascular permeation.
Oral cancer recurrence refers to an oral cancer that
returns following treatment, after a period of time in which
the doctor was unable to detect any signs of this complica-
tion. We used the criteria published by Hong et al. [7]
to distinguish SPTs from recurrences. The definition of SPTs
was based on the following criteria: both tumors were ma-
lignant with histologic confirmation, the two tumors were
geographically distinct (at least 2 cm of normal mucosa be-
tween them) or separated in time by 3 ormore years, and the
possibility that the second primary tumor represented a
metastasis was excluded [7]. In this series, three tumors that
developed within the anatomic vicinity of the primary tumor
were classified as SPTs rather than recurrence after a time
interval of 41 months, 42 months, and 83 months.tical package SPSS for Windows (Version 17.0, SPSS, Inc.,
Chicago, IL, USA). Survival distributions were calculated
using the KaplaneMeier method. Significant differences in
the survival distributions were tested using the log-rank
test. Multivariate survival analysis was conducted using a
Cox proportional hazards model. A p-value <0.05 was
considered to indicate statistical significance.
Results
Clinicopathological characteristics
The subjects comprised 60 (83.3%) men and 12 women
(Table 1). Themedian age at diagnosis was 53.5 years (range:
22e87 years), and the median duration of follow-up was 49
months (range, 6e136 months). Only 15 patients (20.8%) did
Figure 2. Second primary tumor-free survival for all
patients.
556 C.-H. Liu et al.not use tobacco, drink alcohol, or chew betel quid. The
majority of patients (n Z 43, 59.7%) were betel quid
chewers. Tumorswere graded aswell differentiated (52.8%),
moderately differentiated (44.4%), or poorly differentiated
(2.8%) according toWorld Health Organization guidelines. T1
tumors were diagnosed in 44 (61.1%) patients, T2 in 22
(30.6%) patients, and T3 in six (8.3%) patients. Based on the
2002 American Joint Committee on Cancer staging system
[8], there were 44 individuals with Stage I disease, two in-
dividuals with Stage II disease, and six individuals with Stage
III disease. The sites of primary tumor included the tongue in
31 patients, buccal mucosa in 28 patients, gingiva in six
patients, lip in five patients, floor of the mouth in one
patient, and retromolar trigone in one patient. Lip splitting
was required to obtain negative surgical margins in five
patients. Neck dissection was performed in 32 patients
(30 homolaterally, 2 bilaterally). Eleven patients did not
meet the criteria for surgery alone and refused any post-
operative adjuvant therapy. Among them, seven individuals
(9.7%) had positive margins and four individuals (5.6%) had
PNI. These 11 patients received surgery alone for initial
treatment and were included in this study.
Recurrence patterns and salvage treatment
Recurrent disease developed in 18 patients (25%) during the
follow-up period. The median time between surgery and
recurrence was 8.5 months (range: 2e30 months). Recur-
rence occurred within the first 2 years of primary treatment
in 13 (72.2%) patients, and all cases of recurrence occurred
within the first 3 years. The 1- and 3-year overall
recurrence-free survival (RFS) rates were 84.5% and 74.1%,
respectively (Fig. 1). A trend was seen toward lower 3-year
RFS in those patients with positive surgical margins (51.9%)
compared to patients without positive surgical margins or
PNI (78%, p Z 0.083). Seven (38.9%) patients had disease
recurrence only at the primary site, nine (50%) patients had
recurrence only in the ipsilateral neck, and two (11.1%)
patients had simultaneous primary and neck recurrence.
Surgical salvage treatment was attempted in all patients
with tumor recurrence and was successful in 11 (61.1%)
patients (6/7 patients (85.7%) with local recurrence and 5/9Figure 1. Recurrence-free survival (RFS) for all patients.patients (55.6%) with regional recurrence). However, three
patients with regional recurrence developed a second pri-
mary tumor despite regional tumor control (gingiva, nZ 1;
tongue base, n Z 1; and larynx, n Z 1).
Second primary tumors
A total of 20 patients (27.8%) developed SPTs. The median
time from initial treatment of the index tumor to the
diagnosis of the SPT was 32 months (range: 0.5e108
months). Sixteen (80%) cases were diagnosed within 5 years
after treatment of the index tumor. The 3-, 5-, and 7-year
overall SPT-free survival rates were 83%, 73%, and 66%,
respectively (Fig. 2). There was a trend toward lower SPT-
free survival among patients who chewed betel quid
(pZ0.073). The incidence of SPT was 5% per year and was
constant during the follow-up period for at least 7 years. A
total of 18 SPTs (18/20 patients, 90%) occurred in the head
and neck region, including nine SPTs in the buccal area, twoFigure 3. Overall survival (OS) rates for patients with and
without neck recurrence.
Figure 4. Overall survival (OS) rates for patients with and
without second primary tumors (SPT).
Surgery alone for localized oral cancer 557in the gingiva, two in the mouth floor, two in the tongue
base, and one each in the tongue, hard palate, and larynx.
All of those tumors were SCC, and 16 (16/18, 88.9%) of the
patients with SPTs presented with an isolated local disease.
Two SPTs occurred outside the head and neck region,
including one hepatoma and one lymphoma. During the
follow-up period, seven of the 20 patients (35%) with SPT
died due to SPT-related complications.
Overall survival
The 3-, 5-, and 7-year OS rates were 88%, 77%, and 70%,
respectively. Sixteen patients died during the follow-up
period. The associations among various clinicopathological
variables with 5-year OS are listed in Table 1. Patients with
neck recurrence and those with SPT had significantly poorer
OS. The KaplaneMeier OS curves for neck recurrence and SPT
are shown in Figs. 3 and 4, respectively. Neck recurrence and
SPT were associated with 48.4% and 24.4% lower 5-year OS
rates, respectively. Subsequent multivariate Cox regression
analyses of the above factors revealed that neck recurrence
was the only independent predictor of lower OS (pZ 0.008,
hazard ratio: 2.294, 95% confidence interval: 1.247e4.219).
Discussion
Good locoregional control and survival can be obtained
with surgery alone for localized OSCC. In our series, the 3-Table 2 Literature review of outcomes in oral cancer patients
Authors Cases Site Su
Hicks [3], 1998 79 Oral tongue 85; 4-y
Wolfensberger [4], 2001 93 Oral cavity 94; 4-y
Iyer [5], 2004 147 Buccal area 91; 3-y
Lim [6], 2008 76 Oral cavity 69; 5-y
Present study 72 Oral cavity 77; 5-y
NA Z not available.year OS rate was 77%, the 5-year OS rate was 70%, and the
recurrence rate was 21%. These rates were consistent
with those previously reported in the literature (Table 2)
[3e6]. Radiation therapy is an alternative to surgery for
early-stage oral cancers. Although evidence from ran-
domized controlled trials is not available, retrospective
series have suggested that surgery and radiation therapy
yield similar results in terms of local control and survival.
It has been reported that the 5-year locoregional control
rate among patients with oral cavity T1-T2 disease treated
with radiotherapy alone ranges from 69.5% to 81%, and
that the OS rate varies from 46.6% to 81% [9e11]. How-
ever, radiotherapy itself can cause both acute and long-
term complications, including mucositis, dysphagia,
hoarseness, xerostomia, radionecrosis, subcutaneous
fibrosis, trismus, loss of taste, thyroid dysfunction,
esophageal stenosis, dental decay, and damage to the
middle and inner ear [12,13]. Definitive surgical resection
is preferred whenever feasible because of the negative
impact of radiotherapy-related complications on quality
of life.
In the previous published series [3e6], 18% to 28% of oral
cancer patients treated with surgery alone developed
recurrent disease. Wolfensberger et al. [4] reported on a
cohort of 93 patients with early-stage (T1-2, N0-1) oral
cancer treated with surgery alone and found that 47% of
patients developed local disease recurrence and 41%
developed regional recurrence. In our study, the most
common recurrence pattern was regional (50%), followed
by local (38.9%) and locoregional (13%). This pattern was
similar to that reported by Lim et al. [6] who found regional
recurrence in 50% of patients and local recurrence in 31%.
Both positive surgical margins and PNI are predictors of
disease recurrence [14,15]. In the current study, there was
a trend toward lower RFS in patients with positive surgical
margins and PNI (51.9% vs. 78%, p Z 0.083) compared with
patients without these conditions. The small sample size
and good prognosis of this disease may hinder a statistically
significant finding. In addition, an undissected neck [4],
poorly differentiated tumors [5], and neck node metastasis
[6] have been found to be significant predictors for recur-
rence in OSCC patients treated with surgery alone.
The prognosis of salvage surgery for recurrent disease in
patients treated by surgery alone may be better than that
for recurrent disease treated with postoperative radio-
therapy [16,17]. According to our results and the literature
[3e6], salvage treatment is appropriate for most (69e100%)
OSCC patients treated with surgery alone. The average
overall success rate of salvage treatment is approximately
60% (range: 36e71%).treated with surgery alone.
rvival (%) Recurrence no. (%) Salvage rate (%)
disease-specific 22 (28) NA
disease-specific 17 (18) 71
overall 39 (27) 69
overall 16 (21) 36
overall 18 (25) 61
Table 3 Reported salvage treatment for local, regional, and locoregional recurrence.
Local no. Salvage rate (%) Regional no. Salvage rate (%) Locoregional no. Salvage rate (%)
Iyer et al. [5], 2004 18 83.3 11 72.7 10 40
Lim et al. [6], 2008 5 75 8 20 2 0
Present study 7 85.7 9 55.6 2 0
558 C.-H. Liu et al.Few studies have investigated the success rates of
salvage therapy for disease recurrence in patients with oral
cancer that was initially treated with surgery alone. As
shown in Table 3, [6,7] the majority (75e85.7%) of cases of
local recurrence could be salvaged with further treatment.
The success rates of surgical salvage therapy for regional
recurrence were poorer in our series (55.6%) and in the
study by Lim et al. [6] (20%). Iyer et al. [5] reported a high
success rate (72.7%) for surgical salvage therapy in patients
with regional recurrence. However, salvage therapy could
only be performed in 40% of the patients with local or
regional recurrence in their series. The results show the
value of salvage treatment but also demonstrate that not
all patients can be treated with surgical salvage therapy,
especially those with neck recurrence, including regional
and locoregional recurrence. Furthermore, our study
showed that neck recurrence decreased the 5-year OS by
48.4% and that neck recurrence was the only independent
prognostic factor for survival.
Few studies have separately analyzed the occurrence of
SPTs in patients with OSCC that was treated with surgery
alone. In the present study, 72.2% of the recurrent disease
appeared within the first 2 years of diagnosis of the index
OSCC, and the incidence decreased with time. Conversely,
the incidence of SPT remained constant for an extended
period, and its development had a long-term effect on
survival. During the study period, there were a total of 20
cases of SPT development, which corresponds to an inci-
dence of 5% per year, whereas other groups [18,19] noted
an annual incidence of 2.9e3%. A possible explanation for
the discrepancy is that we only included patients with
localized tumors treated with surgery alone. Recently,
some authors reported that SPTs were more likely to occur
in patients with limited initial tumors and in those unex-
posed to radiation [2,20]. In our study, betel quid chewing
seemed to be a risk factor for the development of SPTs. The
majority of patients (nZ 43, 59.7%) in our study were betel
quid chewers. The percentage of OSCC patients in this
study who chewed betel quid (59.7%) was lower than that in
southern Taiwan (82% or higher) [15,18], possibly because
our hospital is in a metropolis where betel chewing is not so
prevalent. Longer follow-up may be necessary, particularly
in those patients who are heavy betel quid chewers.
The majority (15/20, 75%) of SPTs were located in the
oral cavity, a finding compatible with reports from other
betel quid chewing areas (56e70.3%) [18,19]. Most of the
patients (15/18, 83.3%) with second primary head and neck
tumors presented with an isolated local disease. The high
incidence of localized second cancers was probably
because of the intense surveillance and the fact that ra-
diation was not used during the first treatment. According
to the literature [18,19], the esophagus and lung are two ofthe most frequent sites of SPTs outside the oral cavity. This
study had no cases of esophageal or lung SPT, possibly
because of the small number of patients in this study.
In summary, good locoregional control and survival can
be obtained with surgery alone for localized OSCC. Neck
failure was the most common pattern of recurrent disease
and was the only independent prognostic factor for OS. The
incidence of SPT development was high. Further studies
with appropriate follow-up programs and strategies for
preventing the development of SPTs in patients with OSCC
are warranted.References
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